FDA’s Antidepressant MedGuide Coming In January
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency releases a proposed Medication Guide alerting patients and caregivers to pediatric suicidality risk; FDA hopes to finalize language with sponsors by year-end. The MedGuide notes a possible association between antidepressants and “angry or violent” behavior.
You may also be interested in...
FDA Approves Antidepressant "Black Box" Class Labeling
The revised labeling should be available on manufacturers' web pages within two weeks and on all products within 30 days, FDA says. Medication Guides should be available to pharmacists by Jan. 31, the agency says.
FDA Approves Antidepressant "Black Box" Class Labeling
The revised labeling should be available on manufacturers' web pages within two weeks and on all products within 30 days, FDA says. Medication Guides should be available to pharmacists by Jan. 31, the agency says.
FDA Antidepressant Safety Plan Includes "Black Box," Unit-Of-Use Packaging
Unit-of-use packaging will ensure distribution of patient MedGuides, FDA says. Agency asks all antidepressant manufacturers to add "black box" warning, as recommended by advisory committee in September.